Cargando…
Using the influenza vaccine as a mild, exogenous inflammatory challenge: When does inflammation peak?
BACKGROUND: The influenza vaccine has shown promise as a mild, exogenous inflammatory challenge, but use of this model is limited by lack of knowledge about the timing of the inflammatory response. This study was designed to characterize the time-course of the acute inflammatory response and explore...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474380/ https://www.ncbi.nlm.nih.gov/pubmed/34589752 http://dx.doi.org/10.1016/j.bbih.2021.100239 |